CalciMedica CALC Income Statement (2019-2026)

NASDAQ CALC
$0.58 -0.04 (-5.79%)
As of: Aug 20, 2026 · 3:59 PM EDT
Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
-0.48M-0.37M-1.06M0.21M-0.24M-0.10M-2.96M-0.17M-0.21M-0.27M
Operating items
Research & Development (Quarter)
4.02M4.27M2.92M2.26M1.24M1.92M6.49M3.81M2.77M2.78M2.94M4.16M3.55M3.83M4.22M4.05M3.85M3.11M3.48M2.10M
Selling, General & Administrative (Quarter)
4.00M4.43M1.29M1.33M2.04M1.18M15.85M2.77M2.06M1.54M2.82M2.37M2.19M2.34M2.27M2.57M1.77M1.28M2.13M1.91M
Restructuring Costs (Quarter)
0.10M-2.14M
Other Operating Expenses (Quarter)
-0.10M2.14M-0.02M
Operating Expenses (Quarter)
8.02M8.70M4.21M3.59M3.29M3.10M22.34M6.58M4.83M4.32M5.77M6.53M5.74M6.17M6.50M6.62M5.62M4.36M5.61M4.01M
Operating Income (Quarter)
-8.02M-8.70M-4.21M-3.59M-3.29M-3.10M-22.34M-6.58M-4.83M-4.32M-5.77M-6.53M-5.74M-6.17M-6.50M-6.62M-5.62M-4.38M-5.61M-4.01M
EBIT (Quarter)
-8.02M-8.70M-4.21M-3.59M-3.29M-3.10M-22.34M-6.58M-4.83M-4.32M-5.77M-6.53M-5.74M-6.17M-6.50M-6.62M-5.62M-4.38M-5.61M-4.01M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.03M0.04M0.06M0.17M0.31M
Other Non Operating Income (Quarter)
-0.03M-0.05M0.05M-0.12M0.28M0.21M0.17M0.31M0.27M-0.00M0.23M
Non Operating Income (Quarter)
0.58M0.56M0.71M4.52M3.05M0.28M0.21M0.17M5.90M2.58M0.12M1.91M1.46M0.67M-2.19M-6.38M10.59M-3.64M
Net income details
EBT (Quarter)
-8.52M-8.72M-4.28M-3.94M-3.42M-2.90M-22.71M-7.21M-4.87M-4.39M-6.56M-7.17M-7.02M-6.17M-6.94M-6.95M-8.71M-4.71M-5.93M-4.34M
Profit After Tax (Quarter)
-7.99M-8.69M-3.63M-3.03M-2.58M0.10M-19.29M-6.30M-4.62M-4.15M0.13M-3.95M-5.62M-4.26M-5.04M-5.96M-7.80M-10.80M4.98M-7.70M
Income from Continuing Operations (Quarter)
-8.52M-8.72M-4.28M-3.94M-3.42M-2.90M-22.71M-7.21M-4.87M-4.39M-6.56M-7.17M-7.02M-6.17M-6.94M-6.95M-8.71M-4.71M-5.93M-4.34M
Consolidated Net Income (Quarter)
-8.52M-8.72M-4.28M-3.94M-3.42M-2.90M-22.71M-7.21M-4.87M-4.39M-6.56M-7.17M-7.02M-6.17M-6.94M-6.95M-8.71M-4.71M-5.93M-4.34M
Income towards Parent Company (Quarter)
-8.52M-8.72M-4.28M-3.94M-3.42M-2.90M-22.71M-7.21M-4.87M-4.39M-6.56M-7.17M-7.02M-6.17M-6.94M-6.95M-8.71M-4.71M-5.93M-4.34M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-7.99M-8.68M-4.28M-3.94M-3.42M-2.90M-19.29M-6.30M-4.62M-4.15M0.13M-3.95M-5.62M-4.26M-6.94M-6.95M-8.71M-4.71M-5.93M-4.34M
Additional items
EPS (Basic) (Quarter)
-5.25-5.73-2.80-2.57-2.23-1.89-23.43-1.11-0.82-0.920.01-0.36-0.50-0.38-0.49-0.46-0.58-0.31-0.37-0.25
EPS (Diluted) (Quarter)
-5.25-5.73-54.35-2.57-2.23-1.89-23.43-1.11-0.82-0.920.01-0.36-0.50-0.38-0.49-0.46-0.58-0.31-0.36-0.25
Shares Outstanding (Quarter)
1.52M1.51M1.53M1.53M1.54M1.53M0.82M5.66M5.67M4.49M9.75M11.13M11.13M11.25M14.12M15.00M15.08M15.01M15.82M17.10M
Shares Outstanding (Diluted) (Quarter)
1.52M1.51M0.08M1.53M1.54M1.53M0.82M5.66M5.67M4.49M10.05M11.13M11.13M11.25M14.12M15.00M15.08M15.01M16.33M17.10M
Shares Outstanding (Entity) (Quarter)
1.52M1.53M1.53M1.54M1.54M1.53M0.82M5.66M5.68M4.49M10.74M10.75M10.76M13.48M13.97M13.97M14.26M15.44M15.75M17.10M
EBITDA (Quarter)
-8.02M-8.70M-4.21M-3.59M-3.29M-3.10M-22.34M-6.58M-4.83M-4.32M-5.77M-6.53M-5.74M-6.17M-6.50M-6.62M-5.62M-4.38M-5.61M-4.01M
Interest Expenses (Quarter)
0.53M0.04M0.10M0.41M0.31M0.10M0.37M0.62M0.04M0.08M0.79M0.64M1.28M0.45M0.32M3.10M0.33M0.32M0.33M